Recent News

• 03.11.2025 - SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2024
• 03.04.2025 - SIGA to Host Business Update Call on March 11, 2025 Following Release of Fourth-Quarter and Full Year 2024 Financial Results
• 01.02.2025 - TEPOXX (tecovirimat) Approved in Japan for the Treatment of Orthopoxviruses
• 12.10.2024 - Interim Results from STOMP Study of SIGA’s Tecovirimat in Treatment of Mpox Announced
• 11.07.2024 - SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2024
• 10.31.2024 - SIGA to Host Business Update Call on November 7 Following Release of Third-Quarter 2024 Financial Results
• 10.31.2024 - SIGA to Host Business Update Call on November 7 Following Release of Third-Quarter 2024 Financial Results

Recent Filings

• 03.11.2025 - EX-99.1 EX-99.1
• 03.11.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.11.2025 - 8-K Current report
• 01.29.2025 - 4 Statement of changes in beneficial ownership of securities
• 12.13.2024 - 8-K Current report
• 12.10.2024 - EX-99.1 EX-99.1
• 12.10.2024 - 8-K Current report
• 11.08.2024 - SC 13G Statement of Beneficial Ownership by Certain Investors
• 11.07.2024 - 8-K Current report
• 11.07.2024 - 10-Q Quarterly report [Sections 13 or 15(d)]